Come up with a name for your new list and we'll add to it:
BacMuno raised a round of funding on August 14, 2017. Investors include
Hong Kong X.
BacMuno is a pharmaceutical biotechnology company developing bacteria-based cancer immuno-therapies for humans and animals through the use of unique Salmonella based technology.…